About Heidi Kempinski
Heidi Kempinski is CEO and director at Praeventix.
Experience
This experience comes from Heidi Kempinski's profile and from SEC filings. For roles taken from filings, the years are when the filings name Heidi Kempinski in the role, so the role may have started earlier or lasted longer.
Praeventix, Inc. Current
Chief Executive Officer (2022 – Present)
Director
2022 – Present · Exton, PA
Develops potential treatments for people with chronic itching and other disorders.
TB
Tellus BioVentures Current
Senior Principal & Operating Executive
2020 – Present
AT
Aegle Therapeutics Current
Chief Operating Officer
2020 – Present
TA
TamuroBio
President & Chief Operating Officer
2022 – 2024
ZB
Zenas BioPharma
Chief Operating Officer (USA)
2020 – 2022
GS
GSK
VP, Business Operations & Strategic Alliances and Integration Lead for TESARO
2019 – 2020
TI
TESARO, Inc.
VP Business Operations & Strategic Alliances
2010 – 2019
AB
Abraxis BioScience
VP, R&D Operations and Program Management
2009 – 2010
EP
Eisai Pharmaceuticals
Sr. Exec. Director Program Management and Strategic Planning
2008 – 2009
MP
MGI Pharma
VP, Program Management
2005 – 2008
Key Colleagues at Startups
The people Heidi Kempinski works with at each company, as listed on that company's latest Form D.
Praeventix, Inc. · Form D/A, Sep 10, 2026
DP
Douglas Pippin, PhD
Executive officer and director
LM
Leon Moulder
Executive Chair
RH
Robert Hankin
Director